This website uses cookies to ensure you get the best experience on our website.

Got it
MenoHello
Symptom Insights
Browse by Symptom
Latest Articles
Symptoms List
Menopause News
HRT 101
HRT Guide
HRT at a Glance
Common Questions
Estradiol + Progesterone: Your HRT Explained
Progesterone Intolerance
Toolkit
Interactive Menopause Quizzes & Self-Assessments
Weight & Nutrition Tools
HRT Price Checker
FSA-Eligible Menopause Products
Menopause Symptom Trackers
Resources
Find a Menopause Specialist
Amazon Favorites for Symptom Relief
GLP-1 Weight Management
Video Library
Gifts for Menopause
Community
About
My Menopause Story
Your Menopause Stories
Join the Conversation
Share Your Thoughts
Share Your Products
Join the Kegel Challenge
Join the Water Challenge
Symptom Relief
MenoHello
Symptom Insights
Browse by Symptom
Latest Articles
Symptoms List
Menopause News
HRT 101
HRT Guide
HRT at a Glance
Common Questions
Estradiol + Progesterone: Your HRT Explained
Progesterone Intolerance
Toolkit
Interactive Menopause Quizzes & Self-Assessments
Weight & Nutrition Tools
HRT Price Checker
FSA-Eligible Menopause Products
Menopause Symptom Trackers
Resources
Find a Menopause Specialist
Amazon Favorites for Symptom Relief
GLP-1 Weight Management
Video Library
Gifts for Menopause
Community
About
My Menopause Story
Your Menopause Stories
Join the Conversation
Share Your Thoughts
Share Your Products
Join the Kegel Challenge
Join the Water Challenge
Symptom Relief

Jul 29, 2024

Could a Weekly Pill Delay Menopause? Rapamycin Research Shows Promise

Pushing Back the Change: Implications for Women's Health and Longevity

What Happened

A groundbreaking pilot study is testing whether rapamycin, a drug originally developed for organ transplant patients, could slow ovarian aging and potentially delay the onset of menopause. Researchers at Columbia University Irving Medical Center are studying the effects of a once-weekly pill to see if it preserves ovarian function in women.

Why It Matters

For decades, menopause was thought to be an unchangeable milestone of life. This research challenges that assumption, raising the possibility of extending fertility, reducing midlife health risks, and transforming how we think about aging in women’s health. If ovarian aging can be slowed, it could not only delay menopause but also protect against conditions linked to estrogen decline, like osteoporosis, cardiovascular disease, and cognitive changes.

What This Means for Women in Perimenopause & Menopause

Even if you’re already in menopause, this line of research is important. It signals that scientists are beginning to prioritize women’s reproductive aging—an area long overlooked in medicine. While the therapy is not yet available, it could someday give future generations of women more options and control over when menopause occurs. For women nearing menopause now, it’s encouraging to know that midlife health is being taken seriously in cutting-edge research.

Access & Availability

Currently, this is an experimental therapy only available in clinical trials. Rapamycin is not approved for delaying menopause, and researchers emphasize that more studies are needed before it could ever become a treatment option for the general public.

Benefits & Risks

  • Potential benefits: Preserving ovarian function, extending fertility, delaying menopausal symptoms, and possibly reducing risks of age-related diseases.
  • Risks & cautions: Rapamycin suppresses the immune system, which could increase infection risk. Long-term effects in healthy women are unknown, and safety is a major focus of the clinical trials.

Next Steps / What to Watch For

The Columbia University team is continuing its research and monitoring participants closely. Larger, longer-term trials will be needed to confirm whether rapamycin can safely and effectively delay menopause. If the findings hold, this could mark one of the most transformative shifts in women’s health care in decades.

What This Means for Your Midlife Health

While rapamycin is not available as a menopause treatment today, the fact that it’s being studied at all is a hopeful sign that the future of midlife care is evolving. We’ll continue to follow this story closely and keep you informed about any breakthroughs that could eventually impact your options.

Further Reading

  • Pilot Study: Can a Weekly Rapamycin Pill Slow Ovarian Aging?
  • Columbia Clinical Trial: Exploring the Possibility of Delaying Menopause
Share
https://www.menohello.com/menopause-headlines/rapamycin-drug-slow-ovarian-aging Copied
Previous Post Next Post
Latest Posts
FDA Exploring Over-the-Counter Access to Vaginal Estrogen
Oct 30, 2026
FDA Updates Labels on 3 More Hormone Therapy Patches and Addresses Supply
Oct 30, 2026
Executive Order Creates Women’s Health Task Force and NIH Division
Oct 30, 2026
Subscribe to Newsletter

Follow me

FDA Exploring Over-the-Counter Access to Vaginal Estrogen
Oct 30, 2026
FDA Exploring Over-the-Counter Access to Vaginal Estrogen
FDA Updates Labels on 3 More Hormone Therapy Patches and Addresses Supply
Oct 30, 2026
FDA Updates Labels on 3 More Hormone Therapy Patches and Addresses Supply
Executive Order Creates Women’s Health Task Force and NIH Division
Oct 30, 2026
Executive Order Creates Women’s Health Task Force and NIH Division

Hot Flashes Deserve Cool Tips.

Get practical menopause insights, symptom solutions, and solidarity delivered to your inbox.

Join Newsletter

Not Sure Where to Start?

Browse our articles by symptom to find what resonates and what might actually help.

Find Your Symptom
MenoHello

About

Our StoryAuthor ProfileEditorial StandardsResources

Connect

Join the Forum Contact Us Share Your Thoughts Collaborate With Us Support MenoHello

Legal

Privacy PolicyMedical DisclaimerTerms of Use

The information on this site is not medical advice. Please read our full disclaimer.

This site uses affiliate links. If you decide to click and purchase through these links, we may earn a small commission—at no extra cost to you.

Thanks for supporting MenoHello!

© 2026 MenoHello. All Rights Reserved.

Rapamycin delay menopause, ovarian aging Rapamycin, delay perimenopause weekly pill, extend fertility Rapamycin, longevity menopause research, Rapamycin ovarian reserve, VIBRANT study Rapamycin, mTOR inhibitor menopause delay, extending female reproductive lifespan, Rapamycin low dose fertility, delaying ovarian aging, Rapamycin anti aging ovaries, extend menopause timeline, off label Rapamycin women, ovarian longevity treatments, delaying natural menopause, mTOR pathway fertility, weekly Rapamycin pill menopause, perimenopause delay science, future of fertility preservation